<- Go Home
Shandong Wit Dyne Health Co.,Ltd.
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, zithromycin granules, rifaximin dry suspension, and dithiothreitol succinate capsules. In addition, it offers information products, such as DLP splicing display units, LCD splicing display units, image splicing processors, communication products, and industrial automation control products; and crystal products. Further, the company is involved in the provision of education services. Shandong Wit Dyne Health Co.,Ltd. was founded in 1993 and is based in Jinan, China.
Market Cap
CNY 6.4B
Volume
2.7M
Cash and Equivalents
CNY 1.6B
EBITDA
CNY 1.2B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CNY 1.8B
Profit Margin
85.13%
52 Week High
CNY 37.08
52 Week Low
CNY 23.61
Dividend
3.64%
Price / Book Value
2.33
Price / Earnings
13.14
Price / Tangible Book Value
2.50
Enterprise Value
CNY 5.1B
Enterprise Value / EBITDA
4.37
Operating Income
CNY 1.0B
Return on Equity
22.21%
Return on Assets
13.43
Cash and Short Term Investments
CNY 2.7B
Debt
N/A
Equity
CNY 4.1B
Revenue
CNY 2.1B
Unlevered FCF
CNY 468.3M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium